Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep;184(3):846-859.
doi: 10.1002/ajmg.c.31842. Epub 2020 Sep 5.

The new landscape of retinal gene therapy

Cristy A Ku  1 , Mark E Pennesi  1
Affiliations
Review

The new landscape of retinal gene therapy

Cristy A Ku et al. Am J Med Genet C Semin Med Genet. 2020 Sep.

Abstract

Novel therapeutics for inherited retinal dystrophies (IRDs) have rapidly evolved since groundbreaking clinical trials for LCA due to RPE65 mutations led to the first FDA-approved in vivo gene therapy. Since then, advancements in viral vectors have led to more efficient AAV transduction and developed other viral vectors for gene augmentation therapy of large gene targets. Furthermore, significant developments in gene editing and RNA modulation technologies have introduced novel capabilities for treatment of autosomal dominant diseases, intronic mutations, and/or large genes otherwise unable to be treated with current viral vectors. We highlight strategies currently being evaluated in gene therapy clinical trials and promising preclinical developments for IRDs.

Keywords: RNA modulation; gene editing; gene therapy; inherited retinal dystrophies.

PubMed Disclaimer

References

REFERENCES

    1. Acland, G. M., Aguirre, G. D., Bennett, J., Aleman, T. S., Cideciyan, A. V., Bennicelli, J., … Jacobson, S. G. (2005). Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness. Molecular Therapy, 12(6), 1072-1082. https://doi.org/10.1016/j.ymthe.2005.08.008
    1. Ait-Ali, N., Fridlich, R., Millet-Puel, G., Clerin, E., Delalande, F., Jaillard, C., … Leveillard, T. (2015). Rod-derived cone viability factor promotes cone survival by stimulating aerobic glycolysis. Cell, 161(4), 817-832. https://doi.org/10.1016/j.cell.2015.03.023
    1. Allocca, M., Doria, M., Petrillo, M., Colella, P., Garcia-Hoyos, M., Gibbs, D., … Auricchio, A. (2008). Serotype-dependent packaging of large genes in adeno-associated viral vectors results in effective gene delivery in mice. Journal of Clinical Investigation, 118(5), 1955-1964. https://doi.org/10.1172/JCI34316
    1. Ashtari, M., Cyckowski, L. L., Monroe, J. F., Marshall, K. A., Chung, D. C., Auricchio, A., … Bennett, J. (2011). The human visual cortex responds to gene therapy-mediated recovery of retinal function. Journal of Clinical Investigation, 121(6), 2160-2168. http://dx.doi.org/10.1172/jci57377
    1. Aukrust, I., Jansson, R. W., Bredrup, C., Rusaas, H. E., Berland, S., Jorgensen, A., … Knappskog, P. M. (2017). The intronic ABCA4 c.5461-10T>C variant, frequently seen in patients with Stargardt disease, causes splice defects and reduced ABCA4 protein level. Acta Ophthalmologica, 95(3), 240-246. https://doi.org/10.1111/aos.13273

Substances